CERO
CERo Therapeutics Holdings, Inc. · NASDAQ
- Sector Finance
- Industry Financial Conglomerates
- Website cero.bio
- Employees(FY) -
- ISIN US71902K1051
Performance
-4.35%
1W
-39.23%
1M
-76.99%
3M
-89.92%
6M
-90.08%
YTD
-90.14%
1Y
Profile
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
Technical Analysis of CERO 2024-05-10
Overview:
In analyzing the technical indicators for CERO stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potenti...
Recent News & Updates
- 2024-05-14 20:00
- 2024-04-29 21:00
- 2024-03-06 18:00
- 2024-02-14 03:48
- 2023-06-04 20:00
Page 1 of 1
previousnext